Restoring Safeguards for Dangerous Abortion Drugs Act
This bill would require the FDA to replace current regulations for mifepristone (the drug sold as Mifeprex) with the 2011 risk management plan, reversing recent changes. It bans the importation of mifepristone into the U.S. (including by mail) and creates a federal civil liability for entities that illegally import or transport the drug, allowing individuals harmed by the drug to sue for damages. The law directly affects drug manufacturers, importers, telehealth providers, and pharmacies that handle mifepristone, and would make it illegal to import the drug regardless of state laws. It does not change how the drug is prescribed or dispensed within the U.S. but targets its importation and imposes new legal consequences for violations.
Bill status
in committee
1 of 4 stages cleared
Introduction
May 2025
Committee Review
Floor Vote
President
Introduced May 6, 2025
Last action May 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
May 6, 2025
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
May 6, 2025
Introduced
Introduced in Senate
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Josh Hawley
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1631
Scope: US
Hi! I can help you understand S 1631. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline